foxo4-dri senolytic human trial Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells Tools to eliminate senescent cells
Tools to eliminate senescent cells Nature FOXO4 DRI Results: What to Expect (2026) Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases[v1] Buy FOXO4 DRI Peptide (Proxofim) 10mg BiotechPeptides Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal
Pay in 4 interest-free payments of $5.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7





